题目8多选题
In April 2017, US FDA allowed marketing of first direct-to-consumer tests that provide risk information for 10 diseases or conditions, includingA. Parkinson's disease, a nervous system disorder impacting movementB. late-onset Alzheimer's disease, a progressive brain disorder that destroys memory and thinking skillsC. celiac disease, a disorder resulting in the inability to digest glutenD. α1 antitrypsin deficiency, a disorder that raises the risk of lung and liver disease